Tilray (NASDAQ:TLRY - Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, October 10th. Analysts expect Tilray to post earnings of ($0.05) per share for the quarter. Parties interested in registering for the company's conference call can do so using this link.
Tilray (NASDAQ:TLRY - Get Free Report) last announced its earnings results on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The company had revenue of $229.90 million for the quarter, compared to the consensus estimate of $226.20 million. Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The company's revenue for the quarter was up 24.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.15) earnings per share. On average, analysts expect Tilray to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Tilray Price Performance
Shares of NASDAQ:TLRY traded up $0.02 during trading on Thursday, reaching $1.70. The company had a trading volume of 38,402,853 shares, compared to its average volume of 25,247,125. The company has a fifty day moving average of $1.79 and a two-hundred day moving average of $1.88. The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $1.32 billion, a P/E ratio of -3.86 and a beta of 2.13. Tilray has a 12 month low of $1.50 and a 12 month high of $2.97.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Featured Articles
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
